# Cent

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cent-2

- Industry: Healthcare
- Headquarters: Bangalore, India
- Website: www.cent.health
- Total disclosed funding: $20M
- Latest round: Series A (Oct 27, 2026)
- Investors on record: 8

## About

Based in India, Cent provides advanced healthcare solutions through its proprietary CCNM™ protocol, integrating diagnostic tools aimed at early detection of health risks and focusing on preventive care. Founded in 2025 by Arpit Garg, Shashank ND & Anshul Khandelwal in Bengaluru, India, CentAI Technologies Private Limited specializes in comprehensive healthcare solutions. Cent offers a comprehensive healthcare solution through its proprietary CCNM™ protocol, integrating full-body MRI, CT scans, genetic testing, and over 100 biomarkers. This approach targets more than 300 health conditions significantly contributing to preventable deaths, focusing on areas such as cancer, cardiac health, neuro health, and metabolic health. Advanced imaging technology and in-depth lab analyses allow Cent to generate detailed health reports assessing organ-level health and identifying potential risks. While primarily targeting the Indian market, Cent also serves health-conscious individuals seeking thorough preventive care and early detection of critical conditions, catering to a wide demographic from personal health seekers to families wanting comprehensive health screenings. Cent operates on a transactional revenue model, where customers pay directly for health checkup services without subscriptions or tiered packages. The flagship offering is the CCNM™ Scan, priced at INR 25,000, which includes a full-body scan with integrated AI-powered insights. Clients typically book appointments for these scans online or with a team, and services are conducted in a structured visit at Cent's facility. The straightforward payment structure emphasizes direct-to-consumer transactions, ensuring tailored health insights and consultations based on individual results. Following the scan, clients receive a comprehensive health report and a personalized consultation with medical specialists to discuss findings and recommendations. In March 2026, Cent raised USD 5 million in seed funding from South Park Commons. The company will use the funding to expand its engineering team, deepen healthcare partnerships, and open dedicated single-purpose early-detection centers across India. In the coming year, Cent plans to develop and launch new diagnostic products based on the CCNM™ protocol, aiming for release in late 2026. The company is also targeting expansion into additional regions within Asia, particularly Southeast Asia, by mid-2027.

## Funding rounds

- Series A, Oct 27, 2026, $15M — South Park Commons, Blume Ventures, Krishan Sridhar, Krishna Sridhar, Sharath Narayana, Aprameya Radhakrishna, Srinivas Narayanan, Arun Sarin
- Seed, Mar 6, 2026, $5M — South Park Commons

## Investors

- South Park Commons (https://capitalatlas.ai/funds/south-park-commons) — Seed, Series A
- Blume Ventures (https://capitalatlas.ai/funds/blume-ventures) — Series A
- Krishan Sridhar — Series A
- Krishna Sridhar — Series A
- Sharath Narayana — Series A
- Aprameya Radhakrishna — Series A
- Srinivas Narayanan — Series A
- Arun Sarin — Series A